These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 184773)

  • 21. Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin.
    Glueck CJ; Tsang RC; Fallat RW; Scheel D
    Pediatrics; 1974 Jul; 54(1):51-5. PubMed ID: 4365953
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma lipids, lipoproteins and apoproteins in a case of apo C-II deficiency.
    Catapano AL; Mills GL; Roma P; La Rosa M; Capurso A
    Clin Chim Acta; 1983 Jun; 130(3):317-27. PubMed ID: 6872264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a). A dose-response study of the effects of cholestyramine in hypercholesterolaemia.
    Vessby B; Kostner G; Lithell H; Thomis J
    Atherosclerosis; 1982 Jul; 44(1):61-71. PubMed ID: 6214264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholestyramine for elevated serum cholesterol.
    Med Lett Drugs Ther; 1974 Apr; 16(8):33-4. PubMed ID: 4362570
    [No Abstract]   [Full Text] [Related]  

  • 25. [A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].
    Mordasini R; Twelsick F; Oster P; Schellenberg B; Raetzer H; Heuck CC; Schlierf G
    Monatsschr Kinderheilkd (1902); 1978 Jul; 126(7):436-40. PubMed ID: 672910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should hyperlipoproteinemia be treated in patients with coronary artery disease?
    Rider AK
    JAMA; 1975 Jul; 233(3):275-7. PubMed ID: 168412
    [No Abstract]   [Full Text] [Related]  

  • 27. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA; Heimann KW
    S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hyperlipidemia.
    Levy RI; Morganroth J; Rifkind BM
    N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta-lipoprotein cholesterol quantitation with polycations.
    Heuck CC; Schlierf G
    Clin Chem; 1977 Mar; 23(3):536-40. PubMed ID: 189954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypercholesterolemia and hypertriglyceridemia in children.
    Fallat RW; Tsang RC; Glueck CJ
    Prev Med; 1974 Sep; 3(3):390-405. PubMed ID: 4413730
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypertriglyceridemia: a relative contraindication to the use of bile acid-binding resins?
    Denke MA; Grundy SM
    Hepatology; 1988; 8(4):974-5. PubMed ID: 3391527
    [No Abstract]   [Full Text] [Related]  

  • 32. Bile acid metabolism in hyperlipoproteinaemia.
    Hellström K; Einarsson K
    Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of combined therapy with bezafibrate and cholestyramine on low-density lipoprotein metabolism in type IIa hypercholesterolemia.
    Series JJ; Caslake MJ; Kilday C; Cruickshank A; Demant T; Lorimer AR; Packard CJ; Shepherd J
    Metabolism; 1989 Feb; 38(2):153-8. PubMed ID: 2643751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colestimide, an anion exchange resin agent, can decrease the number of LDL particles without affecting their size in patients with hyperlipidemia.
    Kishimoto N; Fujii S; Chiba H; Sakuma I; Tsutsui H
    J Cardiol; 2010 Jan; 55(1):65-8. PubMed ID: 20122550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clofibrate raises plasma apoprotein A-I and HDL-cholesterol concentrations.
    Nestel PJ; Hunt D; Wahlqvist ML
    Atherosclerosis; 1980 Dec; 37(4):625-9. PubMed ID: 7459005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of cholestyramine on lipoprotein lipids in patients with primary type IIA hyperlipoproteinemia.
    Weisweiler P; Neureuther G; Schwandt P
    Atherosclerosis; 1979 Jul; 33(3):295-300. PubMed ID: 226105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anion exchange resin].
    Nakaya N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():642-9. PubMed ID: 11347147
    [No Abstract]   [Full Text] [Related]  

  • 38. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III.
    JAMA; 1988 Jul; 260(3):359-66. PubMed ID: 2898027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The biochemical composition and metabolism of lipoproteins in type V hyperlipoproteinaemia.
    Simons LA; Williams PF
    Clin Chim Acta; 1975 Jun; 61(3):341-52. PubMed ID: 168008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
    Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.